MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

JNJ-42041935

CAS No. : 1193383-09-3

MCE 站：JNJ-42041935

产品活性：JNJ-42041935是高效的，竞争性和选择性的脯氨酰羟化酶PHD抑制剂，抑制PHD1，PHD2 和 PHD3的pK_i值分别为7.91±0.04，7.29 ±0.05和7.65±0.09。

研究领域：Metabolic Enzyme/Protease

作用靶点：HIF/HIF Prolyl-Hydroxylase

In Vitro: JNJ-42041935 is the most potent inhibitor of PHD2_181–417 with a pIC₅₀ value of 7.0±0.03. JNJ-42041935 also inhibits full-length PHD1, PHD2, ａnd PHD3 enzymes (pK_i values 7.91±0.04, 7.29 ±0.05, ａnd 7.65±0.09, respectively) .

In Vivo: JNJ-42041935 is used to compare the effect of selective inhibition of PHD to intermittent, high doses (50 μg/kg i.p.) of an exogenous erythropoietin receptor agonist in an inflammation induced anemia model in rats. JNJ-42041935 (100 μmol/kg, once a day for 14 days) is effective in reversing inflammation induced anemia, whereas erythropoietin has no effect. Administration of JNJ-42041935 (100 μmol/kg p.o.) for 5 consecutive days resulted in a 2-fold increase in reticulocytes, an increase in hemoglobin by 2.3 g/dl, ａnd an increase in the hematocrit of 9%. Two hours after oral administration of 300 μmol/kg JNJ-42041935, the bioluminescence over the peritoneal area is increased by 2.2 ± 0.3-fold relative to luciferase-treated vehicle controls in the mouse .

相关产品：Bioactive Compound Library Plus  |  Epigenetics Compound Library  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Reprogramming Compound Library  |  Oxygen Sensing Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Cancer Metabolism Compound Library  |  Angiogenesis Related Compound Library  |  Transcription Factor Targeted Library  |  Roxadustat  |  DMOG  |  PT-2385  |  Belzutifan  |  PX-478  |  LW6  |  Daprodustat  |  Oltipraz  |  BAY 87-2243  |  PT2399  |  KC7F2  |  Molidustat  |  Enarodustat  |  IOX2  |  IOX4  |  Acriflavine  |  Amifostine  |  Chlorogenic acid  |  Vadadustat  |  ML228  |  FG-2216  |  MK-8617  |  Tilorone dihydrochloride  |  Fraxinellone  |  1,4-DPCA  |  IDF-11774  |  SYP-5  |  AKBA  |  Glucosamine  |  Oroxylin A

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。